All Stories

  1. Avian Influenza Virus PB1 Gene in H3N2 Viruses Evolved in Humans To Reduce Interferon Inhibition by Skewing Codon Usage toward Interferon-Altered tRNA Pools
  2. Role of N Terminus-Truncated NS1 Proteins of Influenza A Virus in Inhibiting IRF3 Activation
  3. Functions of the influenza A virus NS1 protein in antiviral defense
  4. An RNA-synthesizing machine
  5. Cellular DDX21 RNA Helicase Inhibits Influenza A Virus Replication but Is Counteracted by the Viral NS1 Protein
  6. 19F NMR Reveals Multiple Conformations at the Dimer Interface of the Nonstructural Protein 1 Effector Domain from Influenza A Virus
  7. Exploring naphthyl-carbohydrazides as inhibitors of influenza A viruses
  8. The virus genome and its replication
  9. The NS1 protein: A master regulator of host and viral functions
  10. Interferon-induced ISG15 pathway: an ongoing virus–host battle
  11. Biochemical and Structural Evidence in Support of a Coherent Model for the Formation of the Double-Helical Influenza A Virus Ribonucleoprotein
  12. Sequence in the Influenza A Virus Nucleoprotein Required for Viral Polymerase Binding and RNA Synthesis
  13. Identification of Influenza Virus Inhibitors Targeting NS1A Utilizing Fluorescence Polarization–Based High-Throughput Assay
  14. Structural basis for the sequence-specific recognition of human ISG15 by the NS1 protein of influenza B virus
  15. Crystal structure of human ISG15 in complex with NS1 N-terminal region from influenza virus B, Northeast Structural Genomics Consortium Target IDs HX6481, HR2873, and OR2
  16. Dimer Interface of the Effector Domain of Non-structural Protein 1 from Influenza A Virus: AN INTERFACE WITH MULTIPLE FUNCTIONS
  17. Synthesis and evaluation of quinoxaline derivatives as potential influenza NS1A protein inhibitors
  18. Influenza A virus strains that circulate in humans differ in the ability of their NS1 proteins to block the activation of IRF3 and interferon-β transcription
  19. The ESEV PDZ-Binding Motif of the Avian Influenza A Virus NS1 Protein Protects Infected Cells from Apoptosis by Directly Targeting Scribble
  20. Structures of influenza A proteins and insights into antiviral drug targets
  21. Species Specificity of the NS1 Protein of Influenza B Virus: NS1 BINDS ONLY HUMAN AND NON-HUMAN PRIMATE UBIQUITIN-LIKE ISG15 PROTEINS
  22. ISG15 conjugation system targets the viral NS1 protein in influenza A virus–infected cells
  23. Emerging antiviral targets for influenza A virus
  24. Interferon-Induced ISG15 Conjugation Inhibits Influenza A Virus Gene Expression and Replication in Human Cells
  25. Influenza A Virus Polymerase Is an Integral Component of the CPSF30-NS1A Protein Complex in Infected Cells
  26. Interaction of the Influenza A Virus Nucleocapsid Protein with the Viral RNA Polymerase Potentiates Unprimed Viral RNA Replication
  27. Structural basis for suppression of a host antiviral response by influenza A virus
  28. Faculty Opinions recommendation of The structural basis for cap binding by influenza virus polymerase subunit PB2.
  29. A site on the influenza A virus NS1 protein mediates both inhibition of PKR activation and temporal regulation of viral RNA synthesis
  30. The H5N1 Influenza Virus NS Genes Selected after 1998 Enhance Virus Replication in Mammalian Cells
  31. Nuclear and Nucleolar Targeting of Influenza A Virus NS1 Protein: Striking Differences between Different Virus Subtypes
  32. Faculty Opinions recommendation of IFN-stimulated gene 15 functions as a critical antiviral molecule against influenza, herpes, and Sindbis viruses.
  33. The mechanism by which influenza A virus nucleoprotein forms oligomers and binds RNA
  34. Retinoic acid inducible gene-I and mda-5 are involved in influenza A virus-induced expression of antiviral cytokines
  35. The primary function of RNA binding by the influenza A virus NS1 protein in infected cells: Inhibiting the 2′-5′ oligo (A) synthetase/RNase L pathway
  36. Binding of the influenza A virus NS1 protein to PKR mediates the inhibition of its activation by either PACT or double-stranded RNA
  37. The CPSF30 Binding Site on the NS1A Protein of Influenza A Virus Is a Potential Antiviral Target
  38. Influenza Virus Virulence and Its Molecular Determinants
  39. Biophysical Characterization of the Complex between Double-Stranded RNA and the N-Terminal Domain of the NS1 Protein from Influenza A Virus:  Evidence for a Novel RNA-Binding Mode †
  40. Intracellular warfare between human influenza viruses and human cells: the roles of the viral NS1 protein
  41. Cellular antiviral responses against influenza A virus are countered at the posttranscriptional level by the viral NS1A protein via its binding to a cellular protein required for the 3′ end processing of cellular pre-mRNAS
  42. The potential use of influenza virus as an agent for bioterrorism
  43. Structural Basis for Ubiquitin-like ISG 15 Protein Binding to the NS1 Protein of Influenza B Virus: A Protein–Protein Interaction Function That Is Not Shared by the Corresponding N-terminal Domain of the NS1 Protein of Influenza A Virus
  44. The award of the “Interbrew-Baillet Latour de la Santé — 2002” prize to Robert M. Krug for outstanding contributions to influenza virus research
  45. Human influenza viruses activate an interferon-independent transcription of cellular antiviral genes: Outcome with influenza A virus is unique
  46. Efficient Translation of mRNAs in Influenza A Virus-Infected Cells Is Independent of the Viral 5′ Untranslated Region
  47. Selective nuclear export of viral mRNAs in influenza-virus-infected cells
  48. RNA binding by the novel helical domain of the influenza virus NS1 protein requires its dimer structure and a small number of specific basic amino acids
  49. Induction of Apoptosis by Influenza Virus
  50. Influenza Virus NS1 Protein Interacts with the Cellular 30 kDa Subunit of CPSF and Inhibits 3′ End Formation of Cellular Pre-mRNAs
  51. Regulation of a nuclear export signal by an adjacent inhibitory sequence: The effector domain of the influenza virus NS1 protein
  52. Chimeras Containing Influenza NS1 and HIV-1 Rev Protein Sequences: Mechanism of Their Inhibition of Nuclear Export of Rev Protein–RNA Complexes
  53. A novel RNA-binding motif in influenza A virus non-structural protein 1
  54. Crystal structure of the unique RNA-binding domain of the influenza virus NS1 protein
  55. Surprising Function of the Three Influenza Viral Polymerase Proteins: Selective Protection of Viral mRNAs against the Cap-Snatching Reaction Catalyzed by the Same Polymerase Proteins
  56. The RNA-Binding and Effector Domains of the Viral NS1 Protein Are Conserved to Different Extents among Influenza A and B Viruses
  57. New approach for inhibiting Rev function and HIV-1 production using the influenza virus NS1 protein.
  58. Binding of the Influenza Virus NS1 Protein to Double-Stranded RNA Inhibits the Activation of the Protein Kinase That Phosphorylates the eIF-2 Translation Initiation Factor
  59. The Influenza Virus NS1 Protein Forms Multimers in Vitro and in Vivo
  60. The choice of alternative 5' splice sites in influenza virus M1 mRNA is regulated by the viral polymerase complex.
  61. The influenza virus NS1 protein: a novel inhibitor of pre-mRNA splicing.
  62. Nucleocytoplasmic transport: the influenza virus NS1 protein regulates the transport of spliced NS2 mRNA and its precursor NS1 mRNA.
  63. The Influenza Viruses
  64. Expression and Replication of the Influenza Virus Genome
  65. Regulation of splicing of influenza viral NS1 mRNA
  66. Splicing of influenza viral NS1 mRNA
  67. Synthesis of influenza viral genome templates
  68. Translational control in influenza virus-infected cells
  69. Expression of functional influenza viral cap-recognizing protein, the PB2 protein, using eukaryotic vectors
  70. Expression of a functional influenza viral cap-recognizing protein by using a bovine papilloma virus vector.
  71. Influenza Viral RNA Transcription
  72. Nuclear-cytoplasmic transport and VAI RNA-independent translation of influenza viral messenger RNAs in late adenovirus-infected cells
  73. MOLECULAR TOPOGRAPHY OF THE INFLUENZA VIRUS P PROTEIN COMPLEX DURING CAPPED RNA-PRIMED MESSENGER RNA SYNTHESIS
  74. Molecular model of a eucaryotic transcription complex: Functions and movements of influenza P proteins during capped RNA-primed transcription
  75. Transcription and Replication of Influenza Viruses
  76. Studies on the helical nucleocapsid of influenza virus
  77. Role of two of the influenza virus core P proteins in recognizing cap 1 structures (m 7 GpppNm) on RNAs and in initiating viral RNA transcription
  78. Influenza virus, an RNA virus, synthesizes its messenger RNA in the nucleus of infected cells
  79. A unique cap(m7GpppXm)-dependent influenza virion endonuclease cleaves capped RNAs to generate the primers that initiate viral RNA transcription
  80. THE INITIATION OF INFLUENZA VIRAL RNA TRANSCRIPTION BY CAPPED RNA PRIMERS
  81. The 5′ ends of influenza viral messenger RNAs are donated by capped cellular RNAs
  82. Selected host cell capped RNA fragments prime influenza viral RNA transcription in vivo
  83. Both the 7-methyl and the 2'-O-methyl groups in the cap of mRNA strongly influence its ability to act as primer for influenza virus RNA transcription.
  84. CAPPED EUKARYOTIC MESSENGER RNAs ARE PRIMERS FOR INFLUENZA VIRAL RNA TRANSCRIPTION1
  85. Identification of the RNA region transferred from a representative primer, β-globin mRNA, to influenza mRNA during in vitro transcription
  86. Are the 5′ ends of influenza viral mrnas synthesized in vivo donated by host mRNAs?
  87. INFLUENZA VIRAL RNA TRANSCRIPTS SYNTHESIZED IN VIVO AND IN VITRO
  88. Studies on the intranuclear localization of influenza virus-specific proteins
  89. Influenza viral messenger RNA
  90. Cytoplasmic and nuclear virus-specific proteins in influenza virus-infected MDCK cells
  91. Cytoplasmic and nucleoplasmic viral RNPs in influenza virus-infected MDCK cells
  92. Influenza viral RNPs newly synthesized during the latent period of viral growth in MDCK cells